Prescribing trends of SGLT2 inhibitors among HFrEF and HFpEF patients with and without T2DM, 2013-2021.

BMC Cardiovasc Disord · 2024 · PMC11137883 · PMID 38816795

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

failed to reach significancep = 0.08so close (0.05 < p ≤ 0.1)

However, the trend observed among the HFrEF-only stratum failed to reach significance ( p = 0.08).

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.